The development of the next generation of Schema Therapy instruments.
A team of international experts recently proposed a reformulation of the theory underlying Schema Therapy - a validated approach for treating personality disorders and chronic mental health issues.
Schema therapy is a relatively new and effective psychological treatment method for mental disorders that integrates elements from cognitive behavioral therapy, gestalt therapy, object relations theory, psychodynamic therapy, and social constructivism. In schema therapy, the focus is on so-called early maladaptive schemas (fundamental negative beliefs about oneself and relationships with others), coping styles (the way early maladaptive schemas are managed), and schema modes (the schemas and coping methods that are currently activated). Questionnaires have been developed to map early maladaptive schemas, coping styles, and schema modes, which are also often used in other types of psychotherapy besides schema therapy, especially the Young Schema Questionnaire.
In recent years, there has been an international effort to create new assessment instruments for early maladaptive schemas, coping styles, and schema modes. Approximately 30 countries are currently participating in a project where these new instruments are being translated and tested in clinical and non-clinical samples. We at the Department of Psychology at UiT The Arctic University of Norway are participating in this project and have translated the Young Schema Questionnaire (YSQ-S4), Schema Coping Inventory (SCI-R), and Schema Mode Inventory (SMI-3) into Norwegian and are now seeking participants for the empirical testing of the questionnaires, both patients and non-patients. The project focuses on revising the three main self-report tools used in schema therapy: the Young Schema Questionnaire, Schema Coping Inventory, and Schema Mode Inventory. We are conducting the first study to test the reliability and validity of the newly revised schema therapy tools (YSQ, SCI, and SMI). This research aims to extend the framework's application to a broader range of mental disorders.
This is an international consortium (ISTIC) for the translation and validation of schema therapy instruments.